Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy

INTRODUCTION: Various types of dermatological manifestations have been reported due to hepatitis C virus (HCV) infection and anti­HCV therapy. Some of them have been described during IFN-based therapies. PEG-IFN-α-2a/RBV combination is used as the international standard of treatment for HCV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Turker, Kamuran, Tas, Betul, Ozkaya, Murat, Tas, Ebru, Caglar, Aysel, Tetikkurt, Umit Seza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360537/
https://www.ncbi.nlm.nih.gov/pubmed/25821474
http://dx.doi.org/10.5812/hepatmon.24804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360537/
https://www.ncbi.nlm.nih.gov/pubmed/25821474
http://dx.doi.org/10.5812/hepatmon.24804

Ejemplares similares